Obesity Paradox in Atrial Fibrillation: Implications for Outcomes and Relationship With Oral Anticoagulant Drugs

Marco Proietti; Giuseppe Boriani

Disclosures

Am J Cardiovasc Drugs. 2020;20(2):125-137. 

In This Article

Conclusion

Obesity and AF have a strong causal relationship. Some epidemiological data suggest the existence of an obesity paradox for patients with AF. This notwithstanding, the phenomenon appears to be more likely due to incompletely understood pathophysiological mechanisms and to a series of factors and confounders that should be cautiously taken into account. In the comparison between NOACs and VKAs, underweight and healthy weight patients seem to gain the most favorable effects in terms of risk reduction for both stroke and major bleeding.

Comments

3090D553-9492-4563-8681-AD288FA52ACE

processing....